These results have translational relevance since the expression of PPARγ in humans is associated with the progression of NASH [19, 36, 37] and the expression of the PPARγ-regulated CD36 is increased in humans with NASH [18]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.